FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/19/2023
Back to search
Official data from USPTO
MELETIOS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
MELETIOS
ST13
US500000079324895Class
5, 10, 42, 44
Filing
79324895
Registration
6914961
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
04/19/2023
Trademark type
Word
Nice classes
5, 10, 42, 44
Filing date
07/08/2021
Registration date
12/06/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/06/2022
Last transaction
12/06/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
34
Owner location
FR
Examiner
TRUSILO, KELLY
Law office
L70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
M. T. (pessoa física)
Representatives
Lisa C. Pavento Meunier Carlin & Curfman LLC
Technical classification
Nice Classes
Class 5Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparationsanti virals and antibacterials; medical preparations for the treatment of viral and bacterial diseases; Medicines for treating viral and bacterial infections
Class 10
medical diagnostic apparatus for testing for viruses and infections
Class 42
Medical and pharmacological research services; development of pharmaceutical products; scientific research in the nature of conducting clinical trials for third parties; research and development for the pharmaceutical industry; research in the field of pharmaceutical products; pharmaceutical research and development; provision of information in connection with medical and scientific research in the field of pharmaceutical products and clinical trials
Class 44
Health care services for human beings; medical information; medical services; pharmaceutical advice; information services concerning pharmaceutical products; information services relating to medicines; advisory services regarding pharmaceutical products
Publications
History of USPTO decisions and trademark events.
26 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/24/2023
FIMP
FINAL DISPOSITION PROCESSED
03/24/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/06/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/06/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
12/06/2022
GPNX
NOTIFICATION PROCESSED BY IB
09/27/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/20/2022
PUBO
PUBLISHED FOR OPPOSITION
09/20/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/07/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
09/07/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/31/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/16/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/22/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/21/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/21/2022
RFNT
REFUSAL PROCESSED BY IB
06/06/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/13/2022
RFRR
REFUSAL PROCESSED BY MPU
05/12/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/31/2022
CNRT
NON-FINAL ACTION WRITTEN
03/30/2022
DOCK
ASSIGNED TO EXAMINER
03/28/2022
MAFR
APPLICATION FILING RECEIPT MAILED
11/13/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/09/2021
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
11/08/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/04/2021
Continuous trademark protection
Get notified about every new filing that threatens MELETIOS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.